Authors
Latest:
Biomarkers for IgANPanelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.
Latest:
FDA Approves RSV Vaccine for Older AdultsThe approval for Abrysvo represents the second RSV vaccine approved for adults aged 60 years and older in the last month.
Latest:
Empowering Patients: Navigating the Progression Risks of Actinic Keratosis and Optimizing Treatment SelectionIn this episode of MEDcast, expert dermatologists discuss actinic keratosis, a premalignant skin condition. They are sharing their thoughts on the importance of early diagnosis and treatment and are delving into treatment options, in particular photodynamic treatments.
Latest:
Stigma in Epilepsy in 2023: How Far Have We Come?In recent conversations with experts in epilepsy, the impact of stigmatization remains high for patients and ongoing efforts by clinicians to address this issue in the clinical setting has been underscored, despite the global lack of awareness about new treatments and other resources.
Latest:
Targeting Disease Modification for Psoriasis and Psoriatic ArthritisMedical experts engage in a discussion surrounding the treatment and management of patients diagnosed with psoriasis and psoriatic arthritis.
Latest:
Challenges in Managing Type 1 Diabetes and Pressing Need for New TherapiesDrs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes
Latest:
Treatment Decisions and its Relation to Patient AccessibilityFinal thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.
Latest:
Reconsidering Standard of Care for HypercortisolismPanelists discuss how treating hypercortisolism in patients may have long-term effects on glycemic control and overall health, potentially influencing future standards of care for difficult-to-control Type 2 diabetes, while emphasizing the need for clinicians to carefully manage such patients as ongoing research continues.
Latest:
Emerging Treatments of Anhedonia in Patients with Major Depressive DisorderDr Andrew Cutler and Dr Greg Mattingly comment about emerging treatments to treat anhedonia and highlight lifestyle modifications that support the wellbeing of patients with Major Depressive Disorder.
Latest:
Ketamine for the Treatment of MDDRyan Oakley, MD, takes a closer look at the recent history of ketamine in depression. He also explores the differences between ketamine and esketamine.
Latest:
Optimizing Treatment Outcomes in Retinal Vein Occlusion (RVO)A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.
Latest:
Helping Your Patients Avoid the Migraine Trigger TrapForget what you think you know about red wine or chocolate ‘activating’ migraine. Many commonly accepted “triggers” aren’t triggers at all.
Latest:
Bariatric Surgery in Patients Hospitalized with Decompensated Cirrhosis: A Nationwide AnalysisThe retrospective analysis highlights improved outcomes among patients with obesity and a history of bariatric surgery hospitalized with decompensated cirrhosis.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Reducing the Stigma of Unplanned Pregnancy Starts with a ConversationAn unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.
Latest:
Quantifying the Association Between Anxiety and Depressive Features and High Disease Activity Scores in SLEAnxiety and depression can limit engagement with healthcare or treatment leading to later diagnosis, poor treatment adherence, and poor disease control with associated negative sequelae.
Latest:
The Burden of Treatment Resistant DepressionRyan J. Wakim, MD, DFAPA, explores the causes and diagnostic criteria for treatment resistant depression. He also discusses the importance of comprehensive assessment and personalized approaches to care.
Latest:
Generational Trends and Innovations in Retinal Disease TreatmentA panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.
Latest:
Final Thoughts: Awareness and Communication in DiabetesThought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
Latest:
Differential Diagnosis of PBCThe panel of experts focus on strategies for distinguishing primary biliary cholangitis (PBC) from other liver diseases with similar clinical presentations, emphasizing key diagnostic markers and assessment techniques.
Latest:
Addressing Current Treatment Gaps in Pediatric and Adult IBDCurrent treatment limitations in inflammatory bowel disease and the rationale for earlier initiation and use of newer therapies to manage pediatric and adult patients.
Latest:
Current Barriers to uACR TestingPanelists discuss the current barriers to urine albumin-creatinine ratio (uACR) testing, strategies to address these barriers, the guideline goals for reducing uACR, and the importance of a multimodal approach, as well as how increased awareness of chronic kidney disease (CKD) testing can improve patient outcomes and engage health care providers in promoting testing.
Latest:
Community Provider Engagement in HCVMamta Jain, MD, MPH, summarizes community outreach efforts regarding the training and education of health workers.
